Salcura Ltd is a UK based company and was founded by Dr. Martin Schiele, a biomedical research scientist. Its core activities are centred around the research and development of new and very specific diagnostics, natural healthcare supplements and natural therapeutic skincare products. Salcura Ltd has a research network in the UK and across Europe that has resulted in the development of natural skin therapy products, vitamins and supplements using only the finest and most carefully selected ingredients sourced from locations worldwide. As a consequence, Salcura Ltd has achieved a variety of safety certifications for its products, has achieved high quality reviews and recommendations within the industry and has received recognition in worldwide markets and industry events.
 

Salcura Innovation, Performance and Achievement. 



The Salcura range of natural skin therapy products is undoubtedly one of the most innovative and comprehensive product ranges available on today’s market. For this reason Salcura was one of ten companies invited to attend the International Launch of the Institute of Pharmaceutical Innovation (IPI) which was held at the Royal Society – City of London Rooms and the House of Lords, London. With a high profile audience from the NHS, DTI and Department of Health in attendance, Salcura had the opportunity to demonstrate and showcase unique capabilities and product innovations to the industry. Its high performance products are not pharmaceutical but are instead non-pharmaceutical. Their work is based on biotechnology and biological science and due to the strength of its work it was felt that Salcura would add credibility to the event and should be included.

Salcura Achieves – representing the UK


MEDICA Exhibition and Congress, Germany



MEDILINK invited and hosted Salcura Ltd and the Salcura range of natural skin therapy products on the British group stand and very successfully promoted their technologies at the exhibition to a worldwide audience. Feedback from the exhibition has been very encouraging and is now helping Salcura pave the way forward into the international marketplace. 


MEDICA is the world’s largest medical congress and trade fair for medicine and is the key event for the health care technologies sector to showcase and pick up on the latest developments. There were over 4000 exhibitors and over 130,000 visitors from all corners of the world and this invaluable opportunity was only available to 9 invited companies of which Salcura was one those successfully chosen. MEDILINK’S services are specifically designed to highlight a company’s products and profile in international markets with the additional involvement of UK Trade and Investment.

Salcura Performs 



The high quality performance of the products has been one of the main focal points of their work and has lead to many recommendations and appraisals. Salcura’s products have been compared and tested in various ways but no test can be as raw as one made in the media spotlight for everyone to witness. 
The Allergy magazine, in association with Allergy UK (National Allergy Society), performed one such test against a staggering 21 competitors’ products that could be considered for treating eczema.

This is what was published in their magazine: 

“Salcura Intensive is the only product that stops the itching”